Podchaser Logo
Home
KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24

KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24

Released Saturday, 25th May 2024
Good episode? Give it some love!
KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24

KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24

KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24

KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24

Saturday, 25th May 2024
Good episode? Give it some love!
Rate Episode

A PHARMACEUTICAL COMPANY IN INDIA RECENTLY FAILED 10 REQUIREMENTS FOR “GOOD MANUFACTURING PRACTICES” FOLLOWING INSPECTION OF THE FACILITIES BY THE FDA. SO WHAT DOES THAT MEAN FOR THE CONTINUING DRUG SHORTAGES? WE SPEAK WITH KENNETH RAPOZA, INDUSTRY ANALYST FROM THE “COALITION FOR A PROSPEROUS AMERICA” AND FORMER STAFF FOREIGN CORRESPONDENT FOR THE WALL STREET JOURNAL.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features